ZARXIO
Live / Registered — Registered and renewed (as of 24 Mar 2025)
What this means for you
Registered since 27 Oct 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Oct 2025).
Record
- Serial number
- 85804965
- Registration number
- 4841708
- Mark type
- Stylized text
- Filed
- 18 Dec 2012
- Published for opposition
- 07 May 2013
- Registered
- 27 Oct 2015
- Next maintenance due
- 27 Oct 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in stimulating white blood cell production, sold only by prescription
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 24 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 24 Mar 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 24 Mar 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 24 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Nov 2024 — TEAS SECTION 8 & 9 RECEIVED
- 28 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Apr 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Dec 2020 — TEAS SECTION 8 & 15 RECEIVED
- 27 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Oct 2015 — REGISTERED-PRINCIPAL REGISTER
- 22 Sept 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED